Inspiritol – A New Investigational Drug Announced for ME/CFS and Long COVID
A new drug called Inspiritol, has begun the process to too clinical trials in long COVID and chronic fatigue syndrome.
Long-COVID Research Roundup #2: Studies Continue to Suggest Long COVID and ME/CFS/FM are Closely Connected
A Solve M.E.-funded project to uncover and assess the latest Long-COVID research findings made these blogs possible The goal of these continuing research reviews is to find out what researchers are learning about long COVID and how it might apply to chronic fatigue...
NIH Launches Mammoth Effort to Understand and Treat Long COVID
The NIH launches a mammoth effort to quickly understand and find treatments for long COVID that will follow tens of thousands of patients and include hundreds of researchers.
Good Drug, Bad Company? Leronlimab, long COVID, and Bruce Patterson’s Attempt to Takeover CytoDyn
Preliminary results suggested leronlimab may be helpful in long COVID but given Cytodyn's history and current legal challenges it's hard to tell.
“A Huge Problem and Major Crisis”: Avindra Nath on Long COVID at the IACFS/ME 2021 Conference
Avindra Nath reported that long COVID is likely caused by either immune activation or viral persistence, and that the blood vessels and brainstem are likely involved .Lives Interrupted Latest Story
Bob Graybosch
Lahaina, United States
Former occupation: Resort General Manager
$1,261,443
StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
